Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #6422
Reference
Drug alert 03/2019
Name
Drug alert class 4 no 03/2019: medicines defect information: caution in use
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES
Description
Accord Healthcare Limited: Amoxicillin 500mg Capsules BP Accord Healthcare Limited has informed that a change to the Patient Information Leaflet (PIL) for this product has not been implemented by the required timeline. The change concerns the addition of the symptoms of a potential side effect, ‘Drug Reaction with Eosinophilia and Systemic Symptoms’ (DRESS) which is a potentially life-threatening condition. For this reason, it is important that any patients who notice the symptoms seek immediate medical advice.
Contact Name
Irene Fazakerley
Contact Email
Contact Address
St Andrew's House, Regent Road, Edinburgh, EH1 3DG.
Contact Phone
Created
2019-02-04 00:00:00
Click to go back to homepage